
0.2325 Delayed Data As of Jun 24 | ![]() Today’s Change | 0.16 Today|||52-Week Range 1.05 | -26.19% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 0.50. The median estimate represents a +760.22% increase from the last price of 0.23.
The current consensus among 3 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.